Niwanda Yogiswara

Dr. Niwanda Yogiswara

Faculty of Medicine, Airlangga University, Surabaya, Jawa Timur, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
TMTaymour Mostafa
Taymour Mostafa
GPGermar-Michael Pinggera
Germar-Michael Pinggera
MHManaf Al Hashimi
Manaf Al Hashimi
BSBahadır Sahin
Bahadır Sahin
SÇSelahittin Çayan
Selahittin Çayan
Ashok AgarwalAshok Agarwal
Ashok Agarwal
Mostafa T, et al. World J Mens Health. 2025 Feb;43:e9. https://doi.org/10.5534/wjmh.240260

1 October 2022 in Indian Journal of Urology
Verified
Journal Article
Open access
PDF file
FPFirmantya Hadi Pranata
Firmantya Hadi Pranata
YKYudhistira Pradnyan Kloping
Yudhistira Pradnyan Kloping
FHFurqan Hidayatullah
Furqan Hidayatullah
ZRZakaria Aulia Rahman
Zakaria Aulia Rahman
Niwanda YogiswaraNiwanda Yogiswara
Niwanda Yogiswara
DSDoddy Moesbadianto Soebadi
Doddy Moesbadianto Soebadi
Introduction: Transurethral resection of the prostate (TURP) is regarded as the current gold standard surgical intervention for benign prostatic hyperplasia (BPH). However, this procedure is associated with significant chances of intraoperative and postoperative bleeding. Several studies have reported the role of tranexamic acid in prostatic surgeries, but, its role in TURP is still unclear. This review aims to evaluate the role of tranexamic acid in reducing the blood loss during TURP. Materials and Methods: A systematic search was performed on Medline, Scopus, Embase, and Cochrane, up to December 2021. Relevant randomized controlled trials (RCTs) evaluating the role of tranexamic acid in TURP were screened using our predefined eligibility criteria. Data were expressed as odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CIs). All analyses were performed using RevMan 5.4 (Cochrane Collaboration, UK). Results: Six trials were included in this meta-analysis, comprising of 582 patients with BPH who underwent TURP. The meta-analysis revealed an insignificant difference in the rate of blood transfusion (OR 0.68, 95% CI 0.34, 1.34, P = 0.27) but, a significantly lower amount of blood loss and a lower reduction in the hemoglobin (Hb) levels in the patients receiving tranexamic acid as compared to the control group (MD − 127.03, 95% CI − 233.11, −20.95, P = 0.02; MD − 0.53, 95% CI − 0.84, −0.22, P < 0.01; respectively). Also, the operative time (P = 0.12) and the length of hospitalization (P = 0.59) were similar between the two groups. Conclusion: The administration of tranexamic acid was not found to be effective in reducing the need for blood transfusion, the operative time, and the length of hospitalization during the TURP. However, it could reduce the amount of blood loss and the fall in the Hb levels.

3 September 2020 in F1000Research
Verified
Journal Article
Open access
PDF file
FFFarapti Farapti
Farapti Farapti
CFChusnul Fadilla
Chusnul Fadilla
Niwanda YogiswaraNiwanda Yogiswara
Niwanda Yogiswara
MAMerryana Adriani
Merryana Adriani
Background: Hypertension and vitamin D deficiency are prevalent among the elderly. This study evaluated the effects of vitamin D supplementation on changes in serum 25-hydroxyvitamin D (25(OH)D) concentrations and blood pressure (BP) in the elderly (age > 60 years). Methods: Randomized controlled trials from electronic databases on the elderly taking oral vitamin D, until the end of March 2019, were selected. Two reviewers independently screened the literature on the basis of specific inclusion criteria. The primary outcomes were serum 25(OH)D level, systolic BP (SBP), and diastolic BP (DBP) changes. Results: Our analysis revealed significant differences in serum 25(OH)D concentrations changes between the vitamin D and control groups (mean difference [MD] = 13.84; 95% confidence interval [CI] = 10.21–17.47; P < 0.000). There were no significant differences in SBP and DBP changes between the vitamin D and control groups. Subgroup analysis revealed significant differences in SBP changes between the hypertensive and vitamin D-deficient subgroups (MD = –4.01; 95% CI = –7.45 to –0.57; P = 0.02 and MD = –1.91; 95% CI = –3.48 to –0.34; P = 0.02, respectively), and DBP changes only in the hypertensive subgroup (MD = –2.22; 95% CI = –4.1 to –0.34; P = 0.02). Conclusions: Vitamin D supplementation significantly increases 25(OH)D concentrations and seems beneficial in lowering BP, specifically in the elderly with elevated BP and vitamin D deficiency.

5 August 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
FWFandy Wicaksono
Fandy Wicaksono
Niwanda YogiswaraNiwanda Yogiswara
Niwanda Yogiswara
YKYudhistira Pradnyan Kloping
Yudhistira Pradnyan Kloping
JRJohan Renaldo
Johan Renaldo
MSMohammad Ayodhia Soebadi
Mohammad Ayodhia Soebadi
DSDoddy Moesbadianto Soebadi
Doddy Moesbadianto Soebadi
Kidney stone in children is a recurring problem that requires multiple interventions over time. Minimally-invasive approach, such as Extracorporeal Shockwave Lithotripsy (ESWL) is recommended for moderately-sized stones. However, since ESWL is associated with multiple interventions, Micro-Percutaneous Nephrolithotomy (Micro-PCNL) and Retrograde Intrarenal Surgery (RIRS) can also be considered to treat kidney stones in pediatric patients. Both approaches have their respective advantages and disadvantages. In this study, we aimed to compare the efficacy and safety of Micro-PCNL and RIRS in pediatric patients with kidney stones. This systematic review and meta-analysis adhered to the PRISMA guideline and Cochrane Handbook of intervention. The included studies were obtained from the PubMed and ScienceDirect databases. The protocol of this review has been registered in PROSPERO (CRD42021265894). The quality of the studies was assessed using the Newcastle-Ottawa Scale, outcomes were analyzed using STATA®16, and certainty of evidence was evaluated using GRADE. A total of 239 participants were included in this study, divided into the Micro-PCNL (n = 112) and RIRS (n = 127) procedure groups. Statistical analysis revealed a significantly lower requirement of postoperative stenting procedure in Micro-PCNL compared to RIRS (OR 0.09; 95%CI 0.02, 0.47; p < 0.01). However, no significant difference was found in stone-free rate (p = 0.86), operative time (p = 0.09), UTI incidence (p = 0.67), blood transfusion requirement (p = 0.95), and length of stay (p = 0.77). Micro-PCNL is superior to RIRS in managing pediatric kidney stones,10–20 mm in size based on their comparable SFR and fewer requirements of additional stenting procedures.

1 January 2026 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Ashok AgarwalAshok Agarwal
Ashok Agarwal
TMTaymour Mostafa
Taymour Mostafa
MHManaf Al Hashimi
Manaf Al Hashimi
SÇSelahittin Çayan
Selahittin Çayan
EPEdoardo Pescatori
Edoardo Pescatori
RSRupin Shah
Rupin Shah
Agarwal A, et al. World J Mens Health. 2026 Jan;44:e3. https://doi.org/10.5534/wjmh.250290

1 October 2022 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Open access
PKPrihatma Kriswidyatomo
Prihatma Kriswidyatomo
YKYudhistira Pradnyan Kloping
Yudhistira Pradnyan Kloping
MJMerlin Guntur Jaya
Merlin Guntur Jaya
RNRicardo Adrian Nugraha
Ricardo Adrian Nugraha
CPCorinne Prawira Putri
Corinne Prawira Putri
NRNancy Margarita Rehatta
Nancy Margarita Rehatta
PCO2 Gap,Venous-arterial PCO2 difference,Sepsis,Septic Shock